Research Archive — Page 35 of 134
-
November 21, 2023
VUMC scientists discover key step to kidney fibrosis
Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure. -
November 17, 2023
Study validates use of VUMC suicide risk model in Navy primary care
A Vanderbilt study found that automated suicide risk prediction models operating on electronic health records could help clinical teams efficiently identify patients for face-to-face suicide risk screening and prevention. -
November 17, 2023
Tumor antigens key to improving cancer immunotherapy: study
Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients. -
November 16, 2023
Nasty microbe H. pylori has Achilles’ heel
Vanderbilt researchers found that an H. pylori enzyme is essential for colonization of the stomach, suggesting it as a promising therapeutic target for H. pylori infection. -
November 15, 2023
Study finds many patients don’t seek more health services after receiving genetic screening results
A study by Vanderbilt researchers found that more than half of the patients who receive the results of genetic tests might not be impelled to seek more services than they're already receiving. -
November 15, 2023
Twelve at Vanderbilt are among world’s highly cited researchers
Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers. -
November 15, 2023
Novel C. diff structures are required for infection, offer new therapeutic targets
Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs.